PriceSensitive

AusCann Group (ASX:AC8) CEO Layton Mills resigns

ASX News, Health Care
ASX:AC8      MCAP $17.62M
13 September 2022 13:22 (AEST)

This browser does not support the video element.

AusCann Group’s (AC8) Chief Executive Officer has announced his resignation.

After one and a half years, Layton Mills tendered his resignation to the board, citing his desire to pursue other business interests.

The outgoing CEO expressed his appreciation to the company and board for his time in the role.

“I am thankful for the opportunity given to me by the board and shareholders of AusCann during the last 18 months, and would like to personally thank the AusCann board for their support,” Mr Mills said.

“I look forward to following the company’s journey.”

 “We would like to thank Layton for his efforts since AusCann acquired CannPal and wish him well in his future endeavours,” AusCann Chair Tod McGrouther said.

“The board will work closely with Layton to manage the transition throughout the end of the year with a view to appointing a new CEO at the appropriate time.”

Mr Mills said he will continue to support the company during the remainder of his six month notice period while the search for a new CEO begins.

The news comes after the company announced it has invested a further $3.5 million into its joint venture with Australian firm, Eurocann to explore commercial opportunities in the European and local markets.   

AusCann is currently in a trading halt, having last traded at 4 cents on August 31.

Related News